Stockreport

Intercept Pharmaceuticals: Regulatory Snub Unsettles Liver Therapy Front-Runner [Seeking Alpha]

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations
PDF SummaryThe FDA decision has wiped out more than a third of Intercept’s market cap.Yet, the company remains the front runner in the NASH space.The current trading multipl [Read more]